Program Book - Confex

3:00 pm
1595. Knowledge of Clinical Anatomy by Rheumatology Fellows
and Rheumatologists in Latin America
José E. Navarro-Zarza 1 , Cristina Hernández-Díaz 2 , Miguel A.
Saavedra-Salinas 3 , Robert A. Kalish 4 , Juan J. Canoso 5 and Pablo
Villaseñor-Ovies 2 , 1 Mexican Taskforce for the Advancement
of Clinical Anatomy, Mexico, Mexico, 2 Instituto Nacional de
Rehabilitación, Mexico City, Mexico, 3 Centro Médico Nacional,
México, Mexico, 4 Tufts Medical Center, Boston, MA, 5 ABC
Medical Center and Tufts University, Mexico City, Mexico
3:15 pm
1596. Development of a Novel Interactive Case Based
Educational Website In Rheumatology
Christopher E. Collins, Washington Hospital Ctr, Washington, DC
3:30 pm
1597. Revision of Existing Osteoporosis Curriculum in Response
to Fellows Feedback : 2011 Curriculum
Thomas P. Olenginski and Thomas M. Harrington, Geisinger
Medical Center, Danville, PA
3:45 pm
1598. Blog Versus traditional Seminar: A Comparative Trial in
Rheumatology
Elaine L. M. Bezerra 1 , Francisco A. Bezerra Neto 1 , Maria J. Vilar 1
and Grupo de Estudos e Pesquisas em Educação Médica - UFRN 2 ,
1
Federal University of Rio Grande do Norte, Natal, Brazil, 2 Natal,
Brazil
W475a
Epidemiology and Health Services Research I: Gout
Moderators: Jasvinder A. Singh, MD, MPH; University of
Alabama at Birmingham; Birmingham, AL
Hyon Choi, MD, DrPH; Boston University School of Medicine;
Boston, MA
2:30 pm
1599. Allopurinol Initiation and the Risk of Death in the
General Population
Yanyan Zhu 1 , Yuqing Zhang 2 , John D. Seeger 3 , Young Hee Rho 4 ,
Christine Peloquin 1 and Hyon K. Choi 1 , 1 Boston University
School of Medicine, Boston, MA, 2 Boston University Clinical
Edpidemiology Reserach and Training Unit, Boston, MA,
3
Brigham and Women’s Hospital/Harvard Medical School,
Boston, MA, 4 Vanderbilt Medical Center, Nashville, TN
2:45 pm
1600. Increased Gout Risk Related to Diuretic Use Only Exists
for Those with a Higher Genetic Risk: Detection of A Urate
Gene-by-Diuretic Interaction in the Atherosclerosis Risk in
Communities Cohort
Mara McAdams DeMarco 1 , Janet W. Maynard 2 , Alan N. Baer 2 ,
Anna Kottgen 3 , Linda Kao 1 and Josef Coresh 1 , 1 Johns Hopkins
Bloomberg School of Public Health, Baltimore, MD, 2 Johns
Hopkins University, Baltimore, MD, 3 University Hospital Freiburg,
Freiburg, Germany
3:00 pm
1601. Mortality Due to Coronary Heart Disease and Kidney
Disease Among Middle-Aged and Elder Men and Women with
Gout In the Singapore Chinese Health Study
Gim Gee Teng 1 , Li-Wei Ang 2 , Jian-Min Yuan 3 and Woon-Puay
Koh 4 , 1 National University Health System, Singapore, Singapore,
2
Ministry of Health, Singapore, Singapore, 3 Masonic Cancer
Center, University of Minnesota, Minneapolis, MN, 4 Department
of Epidemiology and Public Health, Yong Loo Lin School of
Medicine, National University of Singapore, Singapore, Singapore
3:15 pm
1602. Uncontrolled Serum Uric Acid In Veteran Gout Patients Is
Associated with a Higher Risk of Diabetes
Bhavik J. Pandya 1 , Maryna Marynchenko 2 , Hari Sharma 2 , Andrew
Yu 2 , Eric Wu 2 , Lizheng Shi 3 , Jinan Liu 3 and Eswar Krishnan 4 ,
1
Takeda Pharmaceuticals International, Inc., Deerfield, IL,
2
Analysis Group, Inc., Boston, MA, 3 Tulane University, New
Orleans, LA, 4 Stanford University, Stanford, CA
3:30 pm
1603. Does Treatment of Asymptomatic Hyperuricemia
Improve Cardio and Neurovascular Outcomes A Decision-
Analytic Evaluation
Roopa Akkineni 1 , Alexandra Lee 2 , Katherine L. Miller 3 , Anna N
A. Tosteson 4 , Hyon K. Choi 5 , Yanyan Zhu 5 and Daniel A. Albert 1 ,
1
Dartmouth-Hitchcock Medical Center, Lebanon, NH, 2 Veterans
Affairs National Center for Patient Safety, White River Junction,
VT, 3 Northeastern Ohio Universities College of Medicine,
Rootstown, OH, 4 Dartmouth Medical School, Lebanon, NH,
5
Boston University School of Medicine, Boston, MA
3:45 pm
1604. Comparative Effectiveness of Allopurinol and Febuxostat
In Controlling Serum Uric Acid In a Large US Commercially
Insured Population
Jasvinder A. Singh 1 , Bhavik J. Pandya 2 , Gabriel Gomez Rey 3
and Brett W. Pinsky 4 , 1 University of Alabama at Birmingham,
Birmingham, AL, 2 Takeda Pharmaceuticals International, Inc.,
Deerfield, IL, 3 Innovus, Eden Prairie, MN, 4 Innovus, Lenexa, KS
W190a
Fibromyalgia and Soft Tissue Disorders II
Moderators: Daniel J. Clauw, MD; University of Michigan; Ann
Arbor, MI
Mary-Ann Fitzcharles, MBChB, MD; McGill University; Montreal,
QC, Canada
2:30 pm
1605. Continued Opioid Use in Fibromyalgia Is Associated with
Negative Health Related Outcomes
Peter A. Ste-Marie 1 , Mary-Ann Fitzcharles 2 , Marc-Olivier Martel 2 ,
Ann Gamsa 2 , Pantelis Panopalis 2 and Yoram Shir 2 , 1 University of
Montreal, Montreal, QC, 2 McGill University, Montreal, QC
2:45 pm
1606. 5-HT2C Receptor Agonists Attenuate Muscle Pain in a Rat
Model of Fibromyalgia
Shinichi Ogino, Mina Tsukamoto, Yukinori Nagakura, Tomonari
Watabiki, Yasuaki Shimizu and Hiroyuki Ito, Astellas Pharma Inc.,
Tsukuba, Japan
3:00 pm
1607. Mechanisms of Improvement in Fibromyalgia Symptoms
in a Clinical Trial of Exercise: Increased Fitness or Hawthorne
Effect
Steven A. Mazzuca 1 , Anthony Kaleth 2 , Chandan Saha 3 , James
Slaven3 and Dennis C. Ang 4 , 1 Indiana Univ Schl of Medicine,
MONDAY
November 7, 2011
2011 Program Book 65